Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Agriculture
- Environmental
- University / Academia / Research
- Chemical & Pharmaceuticals
- Water and Wastewater
- Health and Safety
- Manufacturing, Other
- Energy
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- Food and Beverage
- Mining
- Defense
- Commercial
- Construction & Construction Materials
Next Generation Sequencing Suppliers Near Eritrea
124 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inxiamen, CHINA
XIAMEN SPACEGEN Co., Ltd. is a high-tech molecular diagnostic biology enterprise integrating R&D, production, sales and service. The company leads technological innovation guided by clinical needs ,providing high-quality and accessible molecular ...
Detection Gene:KRAS,BRAF,NRAS,PIK3CA,TP53,DYPD,ERBB2,UGT1A1 and MSI(8 genes +MSI). Detection Significance:Guiding individualized diagnosis and treatment of colorectal ...
based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides ...
based inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor ...
based inFairfield, NEW JERSEY (USA)
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. From scientists striving to make research advances to technicians reporting the ...
The Sentosa ST401 System is an automation solution for sequencing template preparation and template enrichment, steps that immediately precede sample sequencing. The system consists of two instrument components, the Sentosa ST401i and Sentosa ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into ...
based inMountain View, CALIFORNIA (USA)
DNAnexus has built the world’s most secure cloud platform and global network for scientific collaboration and accelerated discovery. We embrace challenges and partnership to tackle the world’s most exciting opportunities in human health. We are ...
DNAnexus Titan™ powers the future of genomics research and clinical pipelines with trusted, high-performance data analysis ...
based inChicago, ILLINOIS (USA)
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we ...
Tempus xE (version 2) is a whole exome next-generation sequencing assay that analyzes the entire coding region (exome) of the patient’s genome, combined with whole transcriptome RNA ...
based inMissoula, MONTANA (USA)
FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...
Next-generation sequencing (NGS), also known as high-throughput sequencing, is the comprehensive term used to describe a number of different modern sequencing ...
based inMenlo Park, CALIFORNIA (USA)
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power ...
based inSeoul, Korea, SOUTH KOREA
ChunLab is the world's leading specialist in next generation sequencing and bioinformatics in the fields of microbial genomics, metagenomics and transcriptomics. We have designed a one-stop fully integrated NGS sequencing to bioinformatics pipeline. ...
based inGermantown, MARYLAND (USA)
Based in Germantown, MD, CosmosID®’s CLIA-certified, GCP-compliant laboratory provides the microbiome field with access to standardized and validated metagenomics solutions so that industry, academia & clinicians can unlock the microbiome with ...
based in, INDIA
inDNA Research Labs is an early stage big-data analytics healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by ...
OncoNGx Genomic Workbench is a HIPAA compliant cloud based informatics and clinical annotation platform that will translate sequence (NGS) data from a Cancer diagnostic gene panel into actionable report/information for ...
based inWilmington, NORTH CAROLINA (USA)
AccuGenomics manufactures innovative multiplexed spike-in QC standards (SNAQ-SEQ) that enable a host of highly sensitive next generation sequencing applications. SNAQ-SEQ internal standards improve the accuracy and performance of NGS-based assays. ...
based inNew Haven, CONNECTICUT (USA)
AtlasXomics offers the first comprehensive spatial epigenome technology; AtlasXomics, a 2020 Yale spin-out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. This ...
The DBiT-seq discovery platform combines microfluidics with next generation sequencing. The process starts by adding multi-omic probes (e.g., for mRNA, genomic DNA, or proteins) directly to a tissue ...
based inGuangzhou, CHINA
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy ...
based inRockville, MARYLAND (USA)
Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop ...
based inNottingham, UNITED KINGDOM
Source BioScience is an international provider of integrated state of the art Laboratory Services. Headquartered in the UK, with offices in UK, Europe and the USA, Source BioScience is a fully owned subsidiary of SourceBio International plc, which ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
FUSION GENOMICS ONETest platform offers a complete 12 hours “Benchtop to Desktop” solution for next generation sequencing based diagnostic testing of infectious diseases. The ONETest ...
based inRotkreuz, SWITZERLAND
Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro ...
